Esperite N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
04 nov 2014 - 07:00
Statutaire naam
Esperite N.V.
Titel
Esperite N.V. continues positive trend in Q3 - Synergies between the current business units allow for a successful launch of Genoma activities
Bericht
Esperite N.V. (Euronext: ESP, 'Esperite', or 'the Group'), the European leader in stem cells cryopreservation, now entering the fields of predictive medicine and translational regenerative medicine R&D, announces its trading update for the quarter ended 30 September 2014.
Leveraging the synergies of Esperite's large network of more than 25.000 gynaecologists and over 6.000 hospitals and private clinics has been the platform for a successful start of Genoma's activities.
Gerelateerde downloads
Datum laatste update: 21 december 2025